The abstract is read at the publisher; the summary is JClub's.
Normal telomere attrition acts as a broadly effective tumour-suppressor mechanism that halts emerging cancers when telomeric DNA becomes depleted.
- Why it matters: The work addresses a misconception that telomere shortening is always harmful, and clarifies how telomere dynamics shape lifelong cancer risk.
- What they did: It reviews evidence that telomere attrition limits cell proliferation, that telomere length at birth influences lifelong cancer prevention, and that telomerase activation lets malignant cells bypass the barrier.
- The result: Counteracting telomere attrition in healthy individuals could enable tumour outgrowth, so telomerase activation is best reserved for diseases from excessively short telomeres, while telomerase inhibition is promising for therapy.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.